Trametinib with or without Vemurafenib in BRAF Mutated Non-Small Cell Lung Cancer
Monika Joshi(Penn State Milton S. Hershey Medical Center), Chandra P. Belani(Penn State Milton S. Hershey Medical Center)
Cited by 61
Related Papers
Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers
|Clinical Cancer Research|2007|87